PT2886108T - Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago - Google Patents

Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago

Info

Publication number: PT2886108T
Authority: PT; Portugal
Prior art keywords: optimised; esophagus; treatment; inflammatory changes; pharmaceutical formula
Prior art date: 2013-12-23

Application number

PT13199278T

Other languages

English (en)

Inventor

GREINWALD Roland

Müller Ralph

Pröls Markus

Wilhelm Rudolf

Original Assignee

Dr Falk Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-12-23

Filing date

2013-12-23

Publication date

2019-04-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49911300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2886108(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-12-23 Application filed by Dr Falk Pharma Gmbh filed Critical Dr Falk Pharma Gmbh

2019-04-01 Publication of PT2886108T publication Critical patent/PT2886108T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Physiology (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT13199278T 2013-12-23 2013-12-23 Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago PT2886108T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP13199278.6A EP2886108B2 (de)	2013-12-23	2013-12-23	Optimierte pharmazeutische Formulierung zur Behandlung von entzündlichen Veränderungen des Ösophagus

Publications (1)

Publication Number	Publication Date
PT2886108T true PT2886108T (pt)	2019-04-01

Family

ID=49911300

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT13199278T PT2886108T (pt)	2013-12-23	2013-12-23	Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago
PT14814872T PT3086782T (pt)	2013-12-23	2014-12-18	Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT14814872T PT3086782T (pt)	2013-12-23	2014-12-18	Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago

Country Status (23)

Country	Link
US (4)	US9867780B2 (pt)
EP (2)	EP2886108B2 (pt)
JP (3)	JP6522626B2 (pt)
CN (1)	CN105848648B (pt)
AU (1)	AU2014372739B2 (pt)
CA (1)	CA2934009C (pt)
CY (2)	CY1121168T1 (pt)
DK (2)	DK2886108T4 (pt)
EA (1)	EA029166B1 (pt)
ES (2)	ES2716990T5 (pt)
FI (1)	FI2886108T4 (pt)
HR (2)	HRP20190677T4 (pt)
HU (2)	HUE042009T2 (pt)
IL (1)	IL246172B (pt)
LT (2)	LT2886108T (pt)
PL (2)	PL2886108T5 (pt)
PT (2)	PT2886108T (pt)
RS (2)	RS58543B2 (pt)
SI (2)	SI2886108T2 (pt)
TR (1)	TR201815823T4 (pt)
UA (1)	UA117162C2 (pt)
WO (1)	WO2015097053A1 (pt)
ZA (1)	ZA201604225B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR122022005637B1 (pt)	2009-10-01	2023-03-07	Adare Pharmaceuticals, Inc	Composição farmacêutica líquida não aquosa
WO2015034678A2 (en)	2013-09-06	2015-03-12	Aptalis Pharmatech, Inc.	Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
PT2886108T (pt)	2013-12-23	2019-04-01	Dr Falk Pharma Gmbh	Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago
TWI728172B (zh)	2016-08-18	2021-05-21	美商愛戴爾製藥股份有限公司	治療嗜伊紅性食道炎之方法
KR102862769B1 (ko)	2018-10-24	2025-09-19	훼링 비.브이.	코르티코스테로이드의 점막부착성 제약 조성물
EP4091615A1 (en)	2021-05-20	2022-11-23	Dr. Falk Pharma Gmbh	Orodispersible effervescent tablet comprising budesonide for use in the treatment of eosinophilic esophagitis
CN116869927B (zh) *	2023-09-06	2023-11-10	中国医学科学院北京协和医院	一种用于治疗嗜酸性食管炎的食道温敏凝胶

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3937455A1 (de) *	1989-11-10	1991-05-16	Nordmark Arzneimittel Gmbh	Antacidatabletten
EP0481294B2 (de) *	1990-10-19	2001-04-11	Spirig Ag Pharmazeutische Präparate	Feste, schnell-lösliche Arzneimittelzubereitung enthaltend N-Acetylcystein
DE4332394A1 (de)	1993-09-23	1995-03-30	Falk Pharma Gmbh	Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en)	1995-02-03	1997-06-17	Eurand America, Incorporated	Effervescent microcapsules
US5607697A (en)	1995-06-07	1997-03-04	Cima Labs, Incorporated	Taste masking microparticles for oral dosage forms
US5807577A (en)	1995-11-22	1998-09-15	Lab Pharmaceutical Research International Inc.	Fast-melt tablet and method of making same
US5807578A (en)	1995-11-22	1998-09-15	Lab Pharmaceutical Research International Inc.	Fast-melt tablet and method of making same
US6350470B1 (en)	1998-04-29	2002-02-26	Cima Labs Inc.	Effervescent drug delivery system for oral administration
FR2834893B1 (fr) *	2002-01-23	2004-02-27	Servier Lab	Composition pharmaceutique orodispersible de perindopril
EP1487419A2 (en)	2002-03-20	2004-12-22	Elan Pharma International Limited	Fast dissolving dosage forms having reduced friability
EP1595533B1 (en)	2003-01-21	2010-01-06	Nippon Shinyaku Co., Ltd.	Tablet quickly melting in oral cavity
SE0401031D0 (sv)	2004-04-22	2004-04-22	Duocort Ab	A new glucocorticoid replacement therapy
US20060013873A1 (en)	2004-07-16	2006-01-19	Chih-Chiang Yang	Bioadhesive dosage form of steroids
US20070020330A1 (en)	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
US20070071817A1 (en)	2005-09-26	2007-03-29	Phyzz, Inc.	Effervescent oral care compositions and method of use
US8679545B2 (en) *	2005-11-12	2014-03-25	The Regents Of The University Of California	Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en)	2005-11-12	2012-12-04	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20070191327A1 (en)	2006-02-15	2007-08-16	Verus Pharmaceuticals, Inc.	Sterilization of corticosteroids with reduced mass loss
CA2703501C (en)	2007-10-01	2017-06-13	Laboratorios Lesvi, S.L.	Orodispersible tablets
LT3354276T (lt)	2007-11-13	2020-04-27	Meritage Pharma, Inc.	Kompozicijos, skirtos skrandžio ir žarnyno uždegimo gydymui
US20090264392A1 (en)	2008-04-21	2009-10-22	Meritage Pharma, Inc.	Treating eosinophilic esophagitis
ES2358158T3 (es) *	2008-07-21	2011-05-06	Dr. Falk Pharma Gmbh	Formulación farmacéutica para el tratamiento del tracto digestivo superior.
CA2732105A1 (en)	2008-08-08	2010-02-11	Mcneil-Ppc, Inc.	Use of sucralose as a granulating agent
WO2010144865A2 (en)	2009-06-12	2010-12-16	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders
PT2886108T (pt) *	2013-12-23	2019-04-01	Dr Falk Pharma Gmbh	Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago

2013
- 2013-12-23 PT PT13199278T patent/PT2886108T/pt unknown
- 2013-12-23 ES ES13199278T patent/ES2716990T5/es active Active
- 2013-12-23 EP EP13199278.6A patent/EP2886108B2/de active Active
- 2013-12-23 FI FIEP13199278.6T patent/FI2886108T4/fi active
- 2013-12-23 PL PL13199278.6T patent/PL2886108T5/pl unknown
- 2013-12-23 HU HUE13199278A patent/HUE042009T2/hu unknown
- 2013-12-23 DK DK13199278.6T patent/DK2886108T4/da active
- 2013-12-23 RS RS20190347A patent/RS58543B2/sr unknown
- 2013-12-23 SI SI201331391T patent/SI2886108T2/sl unknown
- 2013-12-23 LT LTEP13199278.6T patent/LT2886108T/lt unknown
- 2013-12-23 HR HRP20190677TT patent/HRP20190677T4/hr unknown
2014
- 2014-12-18 AU AU2014372739A patent/AU2014372739B2/en active Active
- 2014-12-18 HU HUE14814872A patent/HUE041911T2/hu unknown
- 2014-12-18 EP EP14814872.9A patent/EP3086782B1/de active Active
- 2014-12-18 EA EA201600497A patent/EA029166B1/ru not_active IP Right Cessation
- 2014-12-18 TR TR2018/15823T patent/TR201815823T4/tr unknown
- 2014-12-18 PL PL14814872T patent/PL3086782T3/pl unknown
- 2014-12-18 DK DK14814872.9T patent/DK3086782T3/en active
- 2014-12-18 LT LTEP14814872.9T patent/LT3086782T/lt unknown
- 2014-12-18 JP JP2016542264A patent/JP6522626B2/ja active Active
- 2014-12-18 SI SI201430930T patent/SI3086782T1/sl unknown
- 2014-12-18 CN CN201480070548.1A patent/CN105848648B/zh active Active
- 2014-12-18 US US15/107,735 patent/US9867780B2/en active Active
- 2014-12-18 HR HRP20181799TT patent/HRP20181799T1/hr unknown
- 2014-12-18 CA CA2934009A patent/CA2934009C/en active Active
- 2014-12-18 PT PT14814872T patent/PT3086782T/pt unknown
- 2014-12-18 WO PCT/EP2014/078391 patent/WO2015097053A1/de not_active Ceased
- 2014-12-18 UA UAA201608055A patent/UA117162C2/uk unknown
- 2014-12-18 ES ES14814872.9T patent/ES2694331T3/es active Active
- 2014-12-18 RS RS20181398A patent/RS58112B1/sr unknown
2016
- 2016-06-13 IL IL246172A patent/IL246172B/en active IP Right Grant
- 2016-06-22 ZA ZA2016/04225A patent/ZA201604225B/en unknown
2017
- 2017-12-06 US US15/833,428 patent/US10369100B2/en active Active
2018
- 2018-11-21 CY CY20181101233T patent/CY1121168T1/el unknown
2019
- 2019-04-08 CY CY20191100386T patent/CY1121523T1/el unknown
- 2019-04-24 JP JP2019082802A patent/JP6757444B2/ja active Active
- 2019-06-17 US US16/442,756 patent/US10695291B2/en active Active
2020
- 2020-05-15 US US16/875,573 patent/US11382860B2/en active Active
- 2020-08-28 JP JP2020144070A patent/JP7009575B2/ja active Active

Also Published As

Publication number	Publication date
WO2015097053A1 (de)	2015-07-02
EA201600497A1 (ru)	2017-03-31
US9867780B2 (en)	2018-01-16
RS58543B2 (sr)	2023-02-28
EP3086782B1 (de)	2018-09-26
DK2886108T4 (da)	2023-01-30
HUE041911T2 (hu)	2019-06-28
UA117162C2 (uk)	2018-06-25
RS58543B1 (sr)	2019-04-30
SI3086782T1 (sl)	2018-11-30
LT2886108T (lt)	2019-03-25
HRP20181799T1 (hr)	2018-12-28
HUE042009T2 (hu)	2019-06-28
IL246172A0 (en)	2016-07-31
PL2886108T3 (pl)	2019-08-30
JP2019142931A (ja)	2019-08-29
HK1209362A1 (en)	2016-04-01
JP2020196753A (ja)	2020-12-10
US20190358155A1 (en)	2019-11-28
EP2886108B1 (de)	2019-02-06
US20200337997A1 (en)	2020-10-29
LT3086782T (lt)	2018-11-26
EP2886108A1 (de)	2015-06-24
SI2886108T2 (sl)	2023-02-28
AU2014372739B2 (en)	2019-06-13
EA029166B1 (ru)	2018-02-28
PL3086782T3 (pl)	2019-03-29
CA2934009A1 (en)	2015-07-02
EP2886108B2 (de)	2022-11-02
JP7009575B2 (ja)	2022-01-25
IL246172B (en)	2019-01-31
HRP20190677T1 (hr)	2019-05-31
JP6757444B2 (ja)	2020-09-16
TR201815823T4 (tr)	2018-11-21
CY1121523T1 (el)	2020-05-29
ES2716990T5 (es)	2023-03-24
NZ721495A (en)	2020-12-18
CN105848648B (zh)	2019-08-06
US10369100B2 (en)	2019-08-06
FI2886108T4 (fi)	2023-02-22
HRP20190677T4 (hr)	2023-02-03
CN105848648A (zh)	2016-08-10
EP3086782A1 (de)	2016-11-02
ES2694331T3 (es)	2018-12-19
US20160324772A1 (en)	2016-11-10
SI2886108T1 (sl)	2019-05-31
AU2014372739A1 (en)	2016-07-07
CA2934009C (en)	2020-03-10
US10695291B2 (en)	2020-06-30
ES2716990T3 (es)	2019-06-18
PT3086782T (pt)	2018-11-19
CY1121168T1 (el)	2020-05-29
RS58112B1 (sr)	2019-02-28
JP2017500361A (ja)	2017-01-05
US20180185277A1 (en)	2018-07-05
DK3086782T3 (en)	2018-11-26
US11382860B2 (en)	2022-07-12
DK2886108T3 (en)	2019-04-01
ZA201604225B (en)	2017-08-30
PL2886108T5 (pl)	2023-02-27
JP6522626B2 (ja)	2019-05-29

Publication	Publication Date	Title
IL243976B (en)	2020-07-30	kdm1a inhibitors for disease treatment
PT3269716T (pt)	2020-10-09	Novos compostos e suas composições farmacêuticas para o tratamento de doenças inflamatórias
PL3086782T3 (pl)	2019-03-29	Zoptymalizowana formulacja farmaceutyczna do leczenia zmian zapalnych przełyku
PL3062790T3 (pl)	2023-05-15	Połączenia farmaceutyczne do leczenia raka
IL242546A0 (en)	2016-02-01	New compounds for cancer treatment
ZA201603117B (en)	2020-05-27	Withanolides useful for the treatment of neurodegenerative diseases
ZA201507724B (en)	2019-02-27	The treatment of inflammatory disorders
EP3089984A4 (en)	2016-11-09	NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES
GB2528413B (en)	2018-05-23	Inhibition of IL-2 production
IL236870B (en)	2019-11-28	History of hydroxystatin for the treatment of osteoarthritis
PL3016948T3 (pl)	2017-10-31	2-acyloaminotiazole do leczenia nowotworów
GB201306411D0 (en)	2013-05-22	Treatment of inflammatory conditions
IL241331B (en)	2019-10-31	Delay of degenerative diseases
GB201321628D0 (en)	2014-01-22	Treatment of disease
AP2015008905A0 (en)	2015-12-31	Novel compounds for the treatment of cancer
GB201314015D0 (en)	2013-09-18	Novel compound useful for the treatment of degenerative and inflammatory diseases
GB201315079D0 (en)	2013-10-02	Novel compounds useful for the treatment of degenerative and inflammatory diseases
GB201314016D0 (en)	2013-09-18	Novel compounds useful for the treatment of degenerative and inflammatory diseases
GB201303721D0 (en)	2013-04-17	Compositions for treatment of sleep disorders
AU2013900139A0 (en)	2013-01-31	Device for the treatment of snoring